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SUMMARY
Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in Spanish hospitals and
community long-term-care facilities (LTCFs). This longitudinal study was performed in
community LTCFs to determine whether MRSA colonization is associated with MRSA infections
and overall mortality. Nasal and decubitus ulcer cultures were performed every 6 months for an
18-month period on 178 MRSA-colonized residents (86 490 patient-days) and 196 non-MRSA
carriers (97 470 patient-days). Fourteen residents developed MRSA infections and 10 of these were
skin and soft tissue infections. Two patients with respiratory infections required hospitalization.
The incidence rate of MRSA infection was 0.12/1000 patient-days in MRSA carriers and
0.05/1000 patient-days in non-carriers (P=0.46). No diﬀerence in MRSA infection rate was found
according to the duration of MRSA colonization (P=0.69). The mortality rate was 20.8% in
colonized residents and 16.8% in non-carriers ; four residents with MRSA infection died. Overall
mortality was statistically similar in both cohorts. Our results suggest that despite a high
prevalence of MRSA colonization in LTCFs, MRSA infections are neither frequent nor severe
while colonized residents remain at the facility. The epidemiological impact of an MRSA reservoir
is more relevant than the clinical impact of this colonization for an individual resident and
supports current recommendations to control MRSA spread in community LTCFs.
Key words: Epidemiology, geriatrics, long-term care, MRSA, MRSA infections, multiresistant
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INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA)
has a high prevalence in acute-care hospitals in Spain,
and also in long-term-care facilities (LTCFs) [1–3].
This scenario is similar to other countries of the
European Union [4–8]. In the nosocomial setting
patients with persistent MRSA carriage have a higher
risk of developing MRSA infections [9, 10] than
methicillin-susceptible S. aureus (MSSA) carriers and
non-carriers. Although, it appears that MRSA colo-
nization in LTC settings might have diﬀerent clinical
implications than in acute-care hospitals, few studies
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have addressed this issue and most report a low
prevalence of MRSA infection in residents [11, 12]. A
relatively small number of residents require hospital-
ization or die as a consequence of MRSA infections
and this suggests that severe infections are uncommon
in this population. The most frequent MRSA infec-
tions in LTCFs are skin and soft tissue infections
while bloodstream infections account for about 10%
of cases [13].
Very few longitudinal studies have investigated the
incidence of MRSA infections in residents in LTCFs
[12, 14]. We therefore considered it necessary to ana-
lyse the clinical impact of MRSA colonization in this
population in order to identify suitable measures to
prevent spread and infections due to MRSA in this
setting. To this end a multicentre longitudinal study
was performed among residents in community LTCFs
to determine the incidence of MRSA infection and
assess whether MRSA colonization is associated with
greater risk of infection and overall mortality.
METHODS
Study population and characteristics of community
LTCFs
Characteristics of this population have been described
previously [2]. Nine community LTCFs for the elderly,
located in two communities in Spain (Catalonia and
Balearic Islands) with 1586 beds (median 120, range
72–552) were included. Five were located in the catch-
ment area of a 900-bed acute-care hospital (Hospital
Universitari de Bellvitge), three in that of a 490-bed
hospital (Corporacio´ Sanita`ria Parc Taulı´) and one in
that of an 800-bed hospital (Hospital Universitari Son
Dureta). These facilities provide care for the elderly
long-term resident, who may be disabled or inﬁrm.
Each LTCF has a dementia ward and its own medical
staﬀ. Residents are accommodated in rooms with
up to three beds. Surveillance for MRSA and de-
colonization procedures are not routine. In addition
to standard precautions for all patient care, contact
precautions are applied for residents colonized or
infected by MRSA. Known MRSA carriers are not
denied admission [15].
Study design
This was a multicentre prospective cohort study con-
ducted fromNovember 2005 toMay 2007. The studied
population consisted of all residents in the LTCFs at
baseline (n=1377) and was identical to that of our
previously published cross-sectional study [2]. A total
of 231 residents was found to be colonized withMRSA
at baseline (MRSA carriers cohort). A representative
sample of non-MRSA carriers was selected from the
1146 residents without MRSA at baseline as follows:
for each MRSA carrier identiﬁed, one non-MRSA
carrier was randomly selected from the same ward and
screened 6 months later. Those with two consecutive
negative cultures were included in the non-MRSA
carrier cohort (n=196). Subjects were visited by the
investigators every 6months over an 18-month period.
During this period no changes were made to infec-
tion control practices in the LTCFs and data from
the study results were not available to clinical staﬀ.
Decolonization treatment or contact precautions were
not applied to the MRSA carriers detected through-
out the study.
Data collection and deﬁnitions
Complete clinical data were obtained for all residents
at baseline andmedical charts were reviewed thereafter
at 6-monthly intervals. Occurrences of infections, de-
cubitus ulcers, antibiotic use, hospital admission and
deaths were recorded. In the MRSA carrier cohort,
persistent colonization was deﬁned as at least two
MRSA-positive cultures separated by fewer than two
negative cultures. Transient colonization was deﬁned
as two or more negative cultures after a single positive
culture for MRSA [16]. Duration of carriage was de-
ﬁned as the period from the ﬁrst positive culture until
the ﬁrst negative culture with a consecutive negative
culture if available and only residents who survived at
the end of the study were considered for this analysis.
MRSA infection was recorded in the clinical charts of
each facility.
Microbiological methods
Nasal, and where applicable, decubitus ulcer swabs
were obtained for culture every 6 months. Swabs were
placed in Stuart’s transport medium and plated on
coagulase-mannitol agar plates and selective MRSA
agar (MRSA Select, Bio-Rad Laboratories, Spain)
before inoculating into brain heart infusion plus 7%
NaCl. After 24 h of incubation at 35 xC, broths were
subcultured on coagulase-mannitol and selective
MRSA agar; plates were incubated for 48 h and
inspected daily. Putative S. aureus colonies were
identiﬁed by the latex agglutination test (Pastorex1
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Staph-plus, Bio-Rad Laboratories) and DNase
production (DNase Test Agar, Biomedics, Spain).
Methicillin resistance was determined by the cefoxitin
disk diﬀusion method and antimicrobial susceptibility
testing was performed by disk diﬀusion following
Clinical and Laboratory Standards Institute re-
commendations [17].
Statistical analysis
Secondary outcomes (MRSA infections and overall
mortality) were compared between prevalent MRSA
carriers and non-MRSA carriers. Categorical vari-
ables were analysed with x2 or Fisher’s exact tests as
appropriate and continuous variables by Student’s
t test or non-parametric tests.Mortality was compared
by the Kaplan–Meier method. All statistical tests were
two-tailed and P<0.05 was deemed signiﬁcant. SPSS
package version 15.0 was used (SPSS Inc., USA).
Approval for the study was obtained from the
Research Ethics Committee of the Hospital Uni-
versitari de Bellvitge. No written informed consent
was obtained because the study met the criteria for
a waiver of this requirement.
RESULTS
The MRSA cohort comprised 178 colonized residents
(86 490 patient-days) and the non-carrier cohort 196
patients (97 470 patient-days). Over the study period,
147 residents were lost to follow-up (53 at 6 months,
60 at 12 months and 34 at 18 months), 99 residents
died and 30 were discharged. Table 1 compares
residents who were lost to follow-up with those
followed to completion.
Overall 14 residents developed MRSA infections,
nine in the MRSA cohort and ﬁve in the non-carrier
cohort. The type of infections were: 10 skin and soft
tissue infections, seven related to decubitus ulcers,
one urinary tract infection, one chronic external otitis
and two respiratory infections which both required
hospital admission.
The incidence rate of MRSA infection in the total
MRSA cohort (n=178) was 0.12/1000 patient-days
and in the 196 non-carriers, 39 residents acquired
MRSA colonization during the study, giving an inci-
dence rate of MRSA infection in this cohort of 0.05/
1000 patient-days. The incidence rate of MRSA in-
fection was statistically similar for prevalent MRSA
carriers and residents with newly acquired MRSA
colonization (P=0.46). Table 2 shows that no
Table 1. Characteristics of residents who were lost to follow-up with those
followed to completion for the study period
Completed
follow-up
Lost to
follow-up
P(n=280) (n=147)
Female sex, n (%) 191 (68.0) 102 (69.4) 0.08
Age, yr, mean (S.D.) 80.9 (11.6) 83.5 (10.8) 0.06
Charlson Indexo2, n (%) 99 (35.4) 70 (47.6) 0.87
Barthel Index<30, n (%) 101 (36.2) 75 (51.1) 0.009
Decubitus ulcers, n (%) 40 (14.2) 35 (23.8) 0.22
Centre<150 beds n (%) 109 (39.1) 60 (40.8) 0.77
Centre MRSA prevalence>20%, n (%) 172 (61.6) 88 (59.9) 0.15
MRSA colonization, n (%) 128 (45.6) 104 (70.7) 0.17
Two-site colonization, n (%) 17 (5.0) 17 (11.6) 0.59
Infections (all microorganisms), n (%) 152 (54.1) 45 (30.6) 0.34
MRSA infections, n (%) 8 (2.8) 5 (3.4) 0.25
Hospital admissions, n (%) 39 (13.9) 20 (13.6) 0.08
Table 2. Incidence rate of MRSA infection during the
18-month period related to the duration of MRSA
colonization
Duration
of MRSA
colonization
Follow-up
(days)
No. of
MRSA
infections
Incidence
rate of MRSA
infections
<6 months 156 60 3 0.19/1000
patient-days
6 months 9720 0 —
12 months 5205 3 0.58/1000
patient-days
18 months 32 202 2 0.06/1000
patient-days
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diﬀerence was found in MRSA infection rate between
transient and persistent MRSA carriers (lineal re-
gression P=0.69). In addition there were no diﬀer-
ences in infections of any aetiology for both cohorts,
and MRSA carriers did not require more hospital
admissions than non-carriers during the study period
(Table 3). The mortality rate was 20.8% in residents
in the MRSA cohort and 16.8% in non-carriers. Four
of 14 residents with MRSA infection died during the
study period but these were not attributed to MRSA
infection. No statistical diﬀerence was found in the
overall mortality in either group (log rank test 0.19,
P=0.66) (Fig. 1).
DISCUSSION
In a previous study we reported a prevalence of
MRSA colonization of about 17% in residents of
community LTCFs in Spain [2], which represents a
large reservoir of this microorganism in the healthcare
setting. Several studies have highlighted the relevance
of this epidemiological aspect which might inﬂuence
the infection control practices implemented by acute-
care hospitals [18–22] but there are limited data on
the relationship of MRSA colonization and the de-
velopment of infection in residents of LTCFs [12, 14].
This aspect has usually been assessed in settings where
patients are at great risk of MRSA infection, such as
intensive care units [10]. Our ﬁndings show that
MRSA carriers in community LTCFs are not at high
risk of developing severe MRSA infection while
residing at the facility. This is in agreement with
the out-of-hospital risk of MRSA infection reported
in another population [23]. Moreover, from a clinical
point of view, MRSA infections were not severe
and only 2/14 cases required hospitalization. As
previously reported, we found that the main MRSA
infections were skin and soft tissue infections. Re-
markably the majority of infections were associated
with the presence of decubitus ulcers, the most fre-
quent skin lesion in this population. This emphasizes
the need to enhance eﬀorts to prevent the development
of decubitus ulcers. Since in community LTCFs ac-
curate microbiological diagnoses are often lacking,
MRSA infections could have been underestimated
and therefore we analysed the incidence of infection
of any aetiology in both cohorts and found no diﬀer-
ences. Prior studies have demonstrated an incidence
of MRSA infections of 6.5% [13] and a relative risk of
3.6 in MRSA carriers in LTCFs [12].
Persistent MRSA carriers are more often colonized
at multiple sites, are more likely to transmit to others,
and become infected than transient carriers [24].
However, this aspect has not been studied in MRSA-
colonized residents in LTCFs. A recent study per-
formed in a LTCF showed that the degree of bacterial
colonization in persistent MRSA carriers was signiﬁ-
cantly higher than in transient MRSA carriers [14].
We did not ﬁnd a relationship between the incidence
of MRSA infection and the duration of MRSA car-
riage, possibly because of the very few cases of MRSA
infections. Moreover, the incidence of MRSA infec-
tion was similar in prevalent MRSA carriers and re-
sidents with newly acquired MRSA, i.e. MRSA
colonization acquired while residing at the facility. A
recent study, which included a small number of re-
sidents in LTCFs, found that the risk of MRSA in-
fection in long-term carriers in the ﬁrst year exceeded
the risk of infection in subsequent years [23]. It ap-
pears that MRSA carriers remain at considerable
risk for subsequent MRSA infection regardless of
the time since the initial detection of MRSA carriage.
Available data indicate that MRSA colonization
in LTCFs may have diﬀerent and less severe con-
sequences than in acute-care hospitals. The risk of
MRSA infection in the population of community
LTCFs might not be related to the duration of colo-
nization but might instead be attributable to known
risks associated with MRSA infection such as hos-
pitalization, bronchoaspiration, and the presence of
decubitus ulcers or invasive medical devices. Except
for ulcers and bronchoaspiration, these risks are not
frequent in this population [24]. Reports of MRSA
producing Panton–Valentine leukocidin (PVL) strains
in LTCFs are increasing [25–27]. Since these strains
might produce spontaneous infections, MRSA infec-
tion rates could potentially rise in residents in LTCFs
Table 3. Comparison of clinical outcomes in the
MRSA-colonized cohort and the non-carrier cohort
Non-
carriers
MRSA-
colonized
cohort
(N=196) (N=178)
n (%) n (%) RR (95% CI)
MRSA infections 4 (2.1) 10 (4.6) 2.85 (0.88–9.28)
All infections 94 (48.0) 103 (57.9) 1.49 (0.99–2.24)
Hospital
admissions
27 (13.8) 32 (18.0) 1.37 (0.79–2.40)
RR, Relative risk; CI, conﬁdence interval.
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without obvious clonal spread. None of the strains in
this study was PVL positive [2] and previous molecular
typing had shown the presence of only two distinct
clones [16] one of which (CC5-MRSA-IV) has been
reported as widely disseminated in Spanish hospitals
[28, 29].
We found no diﬀerences in overall mortality in
MRSA carriers and non-carriers. The mortality rate
was around 15–20% in this elderly population and
bronchoaspiration was the most frequent cause of
death (data not shown). Previous studies have reported
an associated mortality ofMRSA infections in LTCFs
of 1% [13], and a relative risk overall mortality rate
of 2.0 in MRSA carriers [12]. Signiﬁcantly higher
mortality was associated with MRSA carriers in
LTCFs only in patients with severe cognitive impair-
ment [30].
This study has some limitations, as we only per-
formed cultures of nasal swabs and decubitus ulcers
to detect MRSA colonization. A recent study dem-
onstrated that more than half of community LTCF
residents present multiple-site MRSA colonization
and one-third of MRSA carriers would have been
missed if only nasal swabbing had been performed
[31]. Another limitation is the large number of re-
sidents lost to follow-up, principally because of death
in an elderly population. Patients lost to follow-up
had signiﬁcantly more deterioration in functional
status; this is expected since poor functional status
is associated with death in this population [32].
In addition this study was originally designed to de-
scribe the natural history of MRSA colonization in
residents in LTCFs and to identify risk factors for
being colonizedwithMRSA [16]. TheMRSA infection
rate and mortality in both cohorts were considered as
secondary outcomes, and thus, no speciﬁc calculations
were initially performed to determine if the study
had suﬃcient power to detect signiﬁcant diﬀerences.
Nevertheless, major strengths of this study are the
prospective design and the fact that it includes mul-
tiple facilities with a similar proﬁle. Moreover, MRSA
infections and mortality were evaluated in a popu-
lation with a high prevalence of MRSA carriage.
Community LTCFs are institutions intended for
the promotion of a healthy lifestyle for elderly people,
a segment of population that is growing steadily ;
promoting comfort, optimal social environment and
preserving functional status of residents are major
objectives. The proﬁle of community LTCFs and
the endemicity of MRSA in these centres with a low
clinical impact for colonized residents while in the
facility, make the implementation of control measures
to limit MRSA spread controversial. Standard pre-
cautions for all residents should be applied routinely;
barrier precautions, cohorting, decolonization and
other measures should be undertaken only for con-
trolling MRSA infection outbreaks [33–36]. Our
results together with the clinical experience and
available literature suggest that MRSA infections are
neither frequent nor severe while MRSA-colonized
6005004003002001000
Survival time (days)
1·0
0·8
0·6
0·4
0·2
0·0
Cu
m 
su
rvi
va
l
Non carriers –
censored
MRSA – censored
Non-cariers
MRSA carriers
Survival functions
Fig. 1. Overall mortality during the study period (18 months) for cohorts of MRSA carriers and non-carriers.
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residents remain in a LTCF. However, when admitted
to an acute-care centre, they may spread MRSA to
other patients who may develop severe infections.
Therefore the epidemiological impact of the reservoir
of MRSA in LTCFs is more relevant than the clinical
impact of this colonization for an individual resident.
The present results support current recommendations
to control MRSA spread in community-LTCFs
[33–36].
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